These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 10573075)

  • 1. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
    Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism.
    Li S; Thanikachalam M; Pang M; Carreno M; Aitouche A; Pham SM
    Exp Hematol; 2001 Apr; 29(4):534-41. PubMed ID: 11301194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
    Khan A; Tomita Y; Sykes M
    Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.
    Wekerle T; Sayegh MH; Hill J; Zhao Y; Chandraker A; Swenson KG; Zhao G; Sykes M
    J Exp Med; 1998 Jun; 187(12):2037-44. PubMed ID: 9625763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance.
    Wekerle T; Nikolic B; Pearson DA; Swenson KG; Sykes M
    Transpl Int; 2002 May; 15(5):248-53. PubMed ID: 12012046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade.
    Pilat N; Klaus C; Schwarz C; Hock K; Oberhuber R; Schwaiger E; Gattringer M; Ramsey H; Baranyi U; Zelger B; Brandacher G; Wrba F; Wekerle T
    Am J Transplant; 2015 Jun; 15(6):1568-79. PubMed ID: 25783859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.
    Wekerle T; Kurtz J; Ito H; Ronquillo JV; Dong V; Zhao G; Shaffer J; Sayegh MH; Sykes M
    Nat Med; 2000 Apr; 6(4):464-9. PubMed ID: 10742157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
    Sharabi Y; Abraham VS; Sykes M; Sachs DH
    Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.